What is the fair value of Novozymes AS (OTC-NVZM.F) stock?

The current fair value estimate for Novozymes AS (OTC-NVZM.F) is $62.84. This implies an estimated downside of 6.1% versus the current market price.

Is Novozymes AS (OTC-NVZM.F) undervalued or overvalued?

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 6.1% versus the current market price.

How is the financial health of Novozymes AS?

The current financial health read for Novozymes AS (OTC-NVZM.F) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Novozymes AS's next earnings date?

The next earnings date currently listed for Novozymes AS (OTC-NVZM.F) is November 5, 2026.

Does Novozymes AS (OTC-NVZM.F) pay dividends?

Based on the current data, dividend yield is 1.6%.

What is the P/E ratio for Novozymes AS (OTC-NVZM.F)?

The current P/E ratio listed for Novozymes AS (OTC-NVZM.F) is 42.5x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Novozymes AS?

The current market capitalization listed for Novozymes AS is 31.457 B.

What is the enterprise value of Novozymes AS?

The current enterprise value listed for Novozymes AS is 33.785 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Novozymes AS?

The ticker symbol for Novozymes AS is OTC-NVZM.F, and the stock is listed on OTC Markets.

Where is Novozymes AS (OTC-NVZM.F) listed?

Novozymes AS (OTC-NVZM.F) is listed on OTC Markets.

What is the debt-to-total-capital ratio for Novozymes AS?

The current debt-to-total-capital ratio listed for Novozymes AS is 10.3%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Novozymes AS?

The free float listed for Novozymes AS is 74.4%. Free float helps investors understand how much of the share base is available for public trading.

Novozymes AS (NVZMF) Fair Value & Stock Analysis

Novozymes AS (NVZMF)

Novozymes A/S is a Denmark-based company listed on OTC Markets as common stock. It develops and sells industrial enzymes, functional proteins, and microorganisms used across a wide range of applications. Its solutions support food and beverage production, including dairy, baking, beverages, meat, plant-based products, and other nutrition categories, as well as areas such as bioenergy, household and institutional cleaning, and human health. The company also provides products and technologies for agriculture, animal nutrition, leather and textiles, starch and grain processing, sustainable plastics, oils and fats, and other industrial uses. Novozymes serves customers in Denmark, the rest of Europe, North America, Asia Pacific, the Middle East, Africa, and Latin America, and is headquartered in Lyngby, Denmark.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
OTC-NVZM.F	$62.84	-6.1% Downside	Fair	Not available	Not available	Good	1.6%	November 5, 2026	42.5x	2.4x	6.2x	31.457 B	33.785 B	10.3%	74.4%	14.3	64.2%	134.4%